NCT02041611View on ClinicalTrials.gov

Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 13, 2012

Primary Completion Date

September 2, 2013

Study Completion Date

December 17, 2015

Conditions
High Grade Glioma
Interventions
PROCEDURE

Blood collections

pts will have 6 blood collections (30ml/collection) throughout course of standard treatment

Trial Locations (2)

21231

Johns Hopkins, Baltimore

63110

Washington University, St Louis

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT02041611 - Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas | Biotech Hunter | Biotech Hunter